|
Product Details:
Payment & Shipping Terms:
|
Category: | Elisa Test Kit | Format: | 96T/KIT |
---|---|---|---|
Valid: | 24 Month | Accuracy: | 99.95% |
Sensitivity: | 99.94% | Application: | Toxo IgG |
High Light: | elisa diagnostic kits,rapid elisa test |
Toxoplasma gondii (Toxo) IgG ELISA test, high accuracy, Elisa Sandwich method, for quantitative measurement
Product Name: Toxoplasma gondii (Toxo) IgG ELISA test
Intended Use:
Toxoplasma gondii (Toxo) IgG Enzyme-Linked Immunosorbent Assay (ELISA) is intended for the detection and quantitative determination of IgG antibody to Toxoplasma gondii in human sera. This product is not FDA cleared (approved) for use in testing (ie, screening) blood or plasma donors. For in vitro diagnostic Use. High complexity test.
Summary:
Toxoplasma gondii causes toxoplasmosis, a common disease that affects 30-50 of every 100 people in North America by the time they are adults. The mean source of infection is direct contact with cat feces or from eating undercooked meats. Toxoplasmosis generally presents with mild symptoms in immunocompetent individuals; in the immunocompromised patient, however, the infection can have serious consequences. Acute toxoplasmosis in pregnant women can result in result in miscarriage, poor growth, early delivery or stillbirth. Treatment of an infected pregnant woman may prevent or lessen the disease in her unborn child. Treatment of an infected infant will also lessen the severity of the disease as the child grows. IgG and IgM antibodies to Toxoplasma can be detected with 2-3 weeks after exposure. IgG remains positive, but the antibody level drops overtime. ELISA can detect Toxoplasma IgM antibody after one year after infection in over 50% of patients. Therefore, IgM positive results should be evaluated further with one or two follow up samples if primary infection is suspected.
Principle of Test:
Toxoplasma gondii IgG ELISA Kit is a solid-phase immunoanalytical test. The purified, homogeneous antigen
is fixed to each well of the microtiterstrips. Specific antibodies present in the patient’s sample are bound during
the first incubation step. After removing unbound material by washing, the presence of the specific antibodies
is detected using anti-human IgG conjugate during the second incubation. The unbound peroxidase conjugate
is then removed and TMB substrate is added, resulting in the development of a blue colour. The enzyme
reaction is terminated by addition of the stop solution. The intensity of the colour is proportional to the
concentration of the antibodies in the sample.
Kit Components
Component | Amount |
ELISA break-away strips coated with the specific antigen | 96 wells |
Negative control r.t.u. 1) | 1.2 mL 1 vial |
Calibrator 1 r.t.u., 10 IU 2) | 1.2 mL 1 vial |
Calibrator 2 r.t.u., 50 IU | 1.2 mL 1 vial |
Calibrator 3 r.t.u., 100 IU | 1.2 mL 1 vial |
Calibrator 4 r.t.u., 200 IU | 1.2 mL 1 vial |
Peroxidase conjugate (anti-IgG/Px) r.t.u. | 12 mL 1 vial |
Wash buffer 25x concentrated | 80 mL 1 vial |
Dilution buffer r.t.u. | 100 mL 1 vial |
Chromogenic substrate TMB r.t.u. | 13 mL 1 vial |
Stop solution, r.t.u. | 15 mL 1 vial |
Cover membrane | 3 piece |
Bag with zipper + desiccant | 1 |
1) r.t.u., ready to use | |
2) IU, International Units |
ASSAY PROCEDURE
ORIENT NEW LIFE MEDICAL CO., LTD. | |
Contact: | Jerry Meng |
Email: | Jerry @ newlifebiotest .com |
Tel. | +86 18657312116 |
SKYPE | enetjerry |
Contact Person: Jerry Meng
Tel: +8618657312116